Approximately 50 % of all melanoma families worldwide show linkage to 9p21-22, but only about half of these have been shown to contain germ line CDKN2A mutations. It has been hypothesized that a proportion of these families carry mutations in the noncoding regions of CDKN2A. Several Canadian families have been reported to carry a mutation in the 59 UTR, at position 234 relative to the start site, which gives rise to a novel AUG translation initiation codon that markedly decreases translation from the wild-type AUG (Liu et al., 1999). Haplotype sharing in these Canadian families suggested that this mutation is of British origin. We sequenced 1,327 base pairs (bp) of CDKN2A, making up 1,116 bp of the 59 UTR and promoter, all of exon 1, and 61...
We report six of 16 U.K. melanoma families and two of 17 patients with multiple primary melanomas an...
Although germline mutations in CDKN2A are present in approximately 25% of large multicase melanoma f...
grantor: University of TorontoGermline mutations in the 'CDKN2A' tumor suppressor gene hav...
Approximately 50% of all melanoma families worldwide show linkage to 9p21-22, but only about half of...
Approximately 50% of all melanoma families worldwide show linkage to 9p21–22; however, only about ha...
Germline mutations within the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and one of its targ...
Germ-line mutations in CDKN2A have been shown to predispose to cutaneous malignant melanoma. We have...
Germline mutations of CDKN2A at 9p21 have been shown to predispose to disease in melanoma pedigrees ...
Mutations in two genes encoding cell cycle regulatory proteins have been shown to cause familial cut...
International audienceMutations in two genes encoding cell cycle regulatory proteins have been shown...
Germline mutations in the CDKN2A tumor suppressor gene located on 9p21 have been linked to developme...
Germline mutations in CDKN2 on chromosome 9p21, which codes for the cyclin D kinase inhibitor p16, a...
Germline mutations in the tumor suppressor gene CDKN2A have been shown to predispose to cutaneous ma...
Germline CDKN2A mutations are observed in 20–50 % of melanoma-prone families. We identified melanoma...
Germline mutations in the tumor suppressor gene CDKN2A have been shown to predispose to cutaneous ma...
We report six of 16 U.K. melanoma families and two of 17 patients with multiple primary melanomas an...
Although germline mutations in CDKN2A are present in approximately 25% of large multicase melanoma f...
grantor: University of TorontoGermline mutations in the 'CDKN2A' tumor suppressor gene hav...
Approximately 50% of all melanoma families worldwide show linkage to 9p21-22, but only about half of...
Approximately 50% of all melanoma families worldwide show linkage to 9p21–22; however, only about ha...
Germline mutations within the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and one of its targ...
Germ-line mutations in CDKN2A have been shown to predispose to cutaneous malignant melanoma. We have...
Germline mutations of CDKN2A at 9p21 have been shown to predispose to disease in melanoma pedigrees ...
Mutations in two genes encoding cell cycle regulatory proteins have been shown to cause familial cut...
International audienceMutations in two genes encoding cell cycle regulatory proteins have been shown...
Germline mutations in the CDKN2A tumor suppressor gene located on 9p21 have been linked to developme...
Germline mutations in CDKN2 on chromosome 9p21, which codes for the cyclin D kinase inhibitor p16, a...
Germline mutations in the tumor suppressor gene CDKN2A have been shown to predispose to cutaneous ma...
Germline CDKN2A mutations are observed in 20–50 % of melanoma-prone families. We identified melanoma...
Germline mutations in the tumor suppressor gene CDKN2A have been shown to predispose to cutaneous ma...
We report six of 16 U.K. melanoma families and two of 17 patients with multiple primary melanomas an...
Although germline mutations in CDKN2A are present in approximately 25% of large multicase melanoma f...
grantor: University of TorontoGermline mutations in the 'CDKN2A' tumor suppressor gene hav...